MedTrace Logo

Magnesium Associated With Morphine for Cancer Pain Relief

NCT01541111 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-07-28

No results posted yet for this study

Summary

This study is an evaluation of the analgesic effect of magnesium associated with morphine in patients with cancer pain.

Conditions

  • Cancer-related Problem/Condition

Interventions

DRUG

Magnesiun

75mg pills; each 12h; 12wk

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Rioko K Sakata, MD, PhD · Universidade Federal de São Paulo

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01541111 on ClinicalTrials.gov